Table 1.
Characteristics of respondents who reported smoking or vaping and change thereof during the pandemic
| Smoking (N = 150) | Vaping (N = 110) | |||||||
|---|---|---|---|---|---|---|---|---|
|
No Change (n = 66) |
Smoking More (n = 50) |
Smoking Less (n = 34) |
P-value |
No Change (n = 54) |
Vaping More (n = 26) |
Vaping Less (n = 30) |
P-value | |
| Frequency of use last 30 days, n (%) | ⊗ | ⊗ | ||||||
| Some days | 25 (38%) | 19 (38%) | 8 (24%) | 19 (35%) | 14 (54%) | 4 (13%) | ||
| Every day | 36 (54%) | 31 (62%) | 12 (35%) | 35 (65%) | 12 (46%) | 18 (60%) | ||
| Never (quit in last 30d) | 0 (0%) | 0 (0%) | 14 (41%) | 0 (0%) | 0 (0%) | 7 (23%) | ||
| Did not report | 5 (8%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (3%) | ||
| Age in years, mean (SD) | 46 (16) | 41 (13) | 50 (17) | 0.04 | 43 (15) | 40 (13) | 46 (16) | 0.39 |
| Sex, n (%) | ||||||||
| Female | 39 (59%) | 27 (54%) | 22 (65%) | 0.62 | 27 (50%) | 8 (31%) | 15 (50%) | 0.22 |
| Male | 27 (41%) | 23 (46%) | 12 (35%) | 27 (50%) | 18 (69%) | 15 (50%) | ||
| Race/Ethnicity, n (%) | ||||||||
| Not White | 11 (18%) | 8 (16%) | 9 (29%) | 0.32 | 14 (26%) | 2 (8%) | 7 (24%) | 0.18 |
| White | 51 (82%) | 42 (84%) | 22 (71%) | 40 (74%) | 23 (92%) | 22 (76%) | ||
| Education Level, n (%) | ||||||||
| Associate’s | 16 (24%) | 12 (24%) | 12 (35%) | 0.60 | 12 (22%) | 3 (12%) | 3 (10%) | 0.26 |
| Bachelor’s | 21 (32%) | 20 (40%) | 11 (32%) | 22 (41%) | 8 (31%) | 15 (50%) | ||
| Graduate Level | 29 (44%) | 18 (36%) | 11 (32%) | 20 (37%) | 15 (58%) | 12 (40%) | ||
| Employment, n (%) | ||||||||
| Working | 33 (50%) | 34 (68%) | 21 (62%) | 0.14 | 39 (72%) | 21 (81%) | 21 (70%) | 0.62 |
| Not Working | 33 (50%) | 16 (32%) | 13 (38%) | 15 (28%) | 5 (19%) | 9 (30%) | ||
| COVID Threat Scale Score, mean (SD) | -0.47 (1.08) | 0.04 (0.88) | 0.06 (0.84) | 0.02 | -0.2 (1.04) | -0.11 (0.74) | 0.21 (0.59) | 0.17 |
| PHQ-2 Score, mean (SD) | 2.1 (1.8) | 3.5 (1.7) | 2.0 (2.0) | < 0.01 | 2.2 (2.1) | 2.8 (2.1) | 2.0 (1.4) | 0.38 |
| Depression + Screen, n (%) | ||||||||
| No | 37 (59%) | 13 (36%) | 22 (67%) | 0.03 | 27 (60%) | 11 (61%) | 20 (69%) | 0.72 |
| Yes | 26 (41%) | 23 (64%) | 11 (33%) | 18 (40%) | 7 (39%) | 9 (31%) | ||
| GAD-2 Score, mean (SD) | 2.3 (1.9) | 3.8 (1.7) | 2.5 (2.1) | < 0.01 | 2.8 (2.2) | 3.8 (1.7) | 2.6 (1.6) | 0.04 |
| Anxiety + Screen, n (%) | ||||||||
| No | 37 (57%) | 11 (24%) | 20 (59%) | < 0.01 | 25 (48%) | 7 (28%) | 16 (53%) | 0.14 |
| Yes | 28 (43%) | 34 (76%) | 14 (41%) | 27 (52%) | 18 (72%) | 14 (47%) | ||
N.B.: PHQ-2 = Patient Health Questionnaire, 2 items; GAD-2 = Generalized Anxiety Disorder Questionnaire, 2-items; COVID Threat Scale = factor weighted perceived threat to COVID-19 (novel scale) where each point change is 1 SD change in participant response compared to mean of sample. P-values are ANOVA for continuous items and Chi squared tests for categorical items
⊗ P-value not calculated as groupings inherent to inclusion criteria and are different by definition